Nebulisation of alpha-tocopherol in COPD

G. K. Sharafutdinova, L. A. Nazyrova (Tashkent, Uzbekistan)

Source: Annual Congress 2005 - COPD - treatment III
Session: COPD - treatment III
Session type: Thematic Poster Session
Number: 1961
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. K. Sharafutdinova, L. A. Nazyrova (Tashkent, Uzbekistan). Nebulisation of alpha-tocopherol in COPD. Eur Respir J 2005; 26: Suppl. 49, 1961

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Positive outcomes of 900 mg daily erdosteine in acute exacerbation of COPD
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013


Erdosteine 600mg, but not placebo and NAC 1200mg, restores airway response to inhaled salbutamol 200mcg in COPD
Source: Annual Congress 2007 - Mechanisms and new treatments of COPD
Year: 2007


The sulphoxidation of S-carboxymethyl-L-cysteine in COPD
Source: Eur Respir J 2006; 27: 865-866
Year: 2006


Anti-inflammatory effects of salmeterol/fluticasone propionate (SFC) by smoking status in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 204s
Year: 2005

Anti-oxidant effects of erdosteine in current smokers with mild COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 429s
Year: 2006

Vitamin D deficiency and COPD exacerbations: Effect of vitamin D supplementation
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015

Mucoactive therapy in COPD
Source: Eur Respir Rev 2009; 19: 134-140
Year: 2010



Effect of carbocysteine lysine salt on frequency of exacerbations in COPD patient treated with or without inhaled steroids
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016


Oral iron supplementation with ferric maltol in patients with pulmonary hypertension
Source: Eur Respir J, 56 (5) 2000616; 10.1183/13993003.00616-2020
Year: 2020



Efficacy of erdosteine, carbocysteine, and N-acetylcysteine in COPD: a comparative analysis
Source: International Congress 2019 – Treatment of airway diseases in primary care
Year: 2019

Salmeterol or ipratropium bromide/fenoterol in stable mild-to-moderate COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 426s
Year: 2001

COPD
Source: Eur Respir Monogr 2017; 77: 147-166
Year: 2017


COPD
Source: Eur Respir Monogr 2017; 77: 13-24
Year: 2017


COVID-19 and COPD
Source: Eur Respir J, 56 (2) 2002108; 10.1183/13993003.02108-2020
Year: 2020



COPD
Source: ERS Lung Science Conference 2016
Year: 2016




COPD
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019

COPD
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018

COPD
Source: ERS Skills Course 2016
Year: 2016